Overview:
The Kidney Transplant Disease and Therapy Review provides procedure rates and prevalence numbers and percentages for major countries worldwide. Disease processes which can seriously damage kidneys are included, with discussion of diagnosis and prognosis of kidney disease and transplant. Immunosuppressant treatment options are discussed, with dosing and treatment costs provided. Market size estimates and annual sales of leading therapies are also provided.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
|
Table Of Contents :
I. Overview
General description of the kidney
Conditions leading to kidney transplant
II. incidence and prevalence
Procedure Rates (US, Canada, Argentina, Brazil, Chile, Colombia, Mexico, UK, France, Germany, Greece, Italy, Poland, Russia, Spain, Sweden, Turkey, China, India, Iran, Japan, Korea, Philippines, Saudi Arabia, Thailand, South Africa, Australia, Worldwide)
Prevalence Table (US, Canada, Argentina, Brazil, Chile, Colombia, Mexico, UK, France, Germany, Greece, Italy, Poland, Russia, Spain, Sweden, Turkey, Hong Kong, Korea, Thailand, Australia, Worldwide)
III. diagnosis and prognosis
Factors contributing to transplant decisions
Patient prognosis
IV. treatment
General description of procedure
Medical treatment
V. dosing and treatment costs
Overview of transplant costs
Dosing for commonly prescribed drugs
Costs for commonly prescribed drugs
VI. market size
Overall market size
Sales information for key pharmaceuticals
VII. comments
VIII. references/resources
|
